乳-N-四糖,lacto-N-tetraose
1)lacto-N-tetraose乳-N-四糖
2)lactose[英]['l?kt??s][美]['l?ktos]n.乳糖
3)galactosylated chitosanN-乳糖酰壳聚糖
1.Objective: The aim in this study was to synthesize a novel chitosan derivative, galactosylated chitosan (GC), and prepare norcantharidin-associated galactosylated chitosan nanoparticles (NCTD-GC-NPs) with GC as hepatocyte-targeting carriers and norcantharidin (NCTD) as model drug against primary liver carcinoma.目的:制备含有半乳糖基团的N-乳糖酰壳聚糖(galactosylated chitosan, GC)作为新型肝靶向药物载体。
2.METHODS Norcantharidin-associated galactosylated chitosan nanoparticles were achieved by ionic cross-linkage process with galactosylated chitosan as carrier.方法以N-乳糖酰壳聚糖为载体,通过离子诱导法,制备去甲斑蝥素N-乳糖酰壳聚糖纳米粒。
英文短句/例句

1.Preparation and Characteristic of Norcantharidin-associated Galactosylated Chitosan Nanoparticles去甲斑蝥素N-乳糖酰壳聚糖纳米粒的制备与性质研究
2.Preparation and in Vitro Antineoplastic Activity of Norcantharidi N-Associated Galactosylated Chitosan Nanoparticles去甲斑蝥素N-乳糖酰壳聚糖纳米粒的制备与体外抗肿瘤活性
3.Preparation of norcantharidin N-galactosylated chitosan nanoparticles and its characteristics去甲斑蝥素N-乳糖酰壳聚糖纳米粒的制备及其特性研究
4.Research on the aggregation behavior of N-maleoyl chitosanN-马来酰化壳聚糖聚集行为的研究
5.Design,synthesis and characterization of N-palmityl-N′-aminoacyl chitosan derivativesN-棕榈酰基-N′-氨基酰基壳聚糖衍生物的设计、合成及表征
6.Drug delivery study of temperature-responsive chitosan/poly(N-isopropylacrylamide) semi-interpenetrating-polymer-network beads壳聚糖/聚N-异丙基丙烯酰胺温敏性珠状小球的药物释放研究
7.Stnthesis and Characterization of Thermoresponsive Hydrogels Cross-Linked with N-Malely ChitosanN-马来酰化壳聚糖交联温敏性水凝胶的合成和性质研究
8.Study on the New Homogeneous Synthesis Method of N-Acyl Chitosan in Ionic Liquids离子液体条件下N-酰化壳聚糖的均相合成新工艺研究
9.Preparation of N-caproyl Chitosan Nanoparticles Surface-modified with Glycyrrhizin and Its Stability in Vitro甘草酸表面修饰N-己酰化壳聚糖纳米粒的制备及其稳定性研究
10.Synthesis of N-acyl chitosan derivatives and investigation of chitosan-modified docetaxel liposomes in vitroN-酰化壳聚糖的合成及其修饰多西他赛脂质体的体外性质研究
11.Preparation of N-palmitoyl chitosan and improvement of pharmacokinetics of indirubinN-软脂酰基壳聚糖的制备及其改善靛玉红水溶性的药动学研究
12.Modification of Poly (D, L-Lactic Acid) with Carboxymethyl Chitosan and Chitosan by Copolymerization or Blending;聚乳酸与壳聚糖及羧甲基壳聚糖的改性研究
13.Preparation and performance of low-molecular weight N, O-carboxymethyl-chitosan低聚N,O-羧甲基壳聚糖的制备与性能
14.Preparation and Characterization of N,O-Carboxymethyl Chitosan;N,O-羧甲基壳聚糖的制备及表征
15.Use of Chitosan for Isolation of Beta-lactoglobulin from Whey Powder壳聚糖法提取乳清粉中的β-乳球蛋白
16.Comparison of two chitosan deacetylation degree determination壳聚糖脱乙酰度两种测定方法的比较
17.Co-immobilization of lactase and its application in production of low lactose milk凹凸棒土—壳聚糖耦合固定化乳糖酶及其在低乳糖乳制备中的应用
18.COMPARISON OF ACTION PATTERN OF CHITINASE AND CHITOSANASE ON PARTIALLY N-ACETYLATED CHITOSAN几丁质酶和壳聚糖酶对部分乙酰化壳聚糖作用方式的比较
相关短句/例句

lactose[英]['l?kt??s][美]['l?ktos]n.乳糖
3)galactosylated chitosanN-乳糖酰壳聚糖
1.Objective: The aim in this study was to synthesize a novel chitosan derivative, galactosylated chitosan (GC), and prepare norcantharidin-associated galactosylated chitosan nanoparticles (NCTD-GC-NPs) with GC as hepatocyte-targeting carriers and norcantharidin (NCTD) as model drug against primary liver carcinoma.目的:制备含有半乳糖基团的N-乳糖酰壳聚糖(galactosylated chitosan, GC)作为新型肝靶向药物载体。
2.METHODS Norcantharidin-associated galactosylated chitosan nanoparticles were achieved by ionic cross-linkage process with galactosylated chitosan as carrier.方法以N-乳糖酰壳聚糖为载体,通过离子诱导法,制备去甲斑蝥素N-乳糖酰壳聚糖纳米粒。
4)N-alkyl-lactosylated-ON-烷基乳糖基-O
1.N-alkyl-lactosylated-O,N-carboxymethyl chitosan are prepared by carboxymethyl-chitosan with alkyldehyde and lactose.通过羧甲基壳聚糖与醛和乳糖反应制得N-烷基乳糖基-O,N-羧甲基壳聚糖,并以戊二醛为交联剂制成水凝胶;以人血清蛋白作为模型药物,初步探讨了该水凝胶对蛋白类药物的释放规律。
5)N-acetylgalactosamineN-乙酰半乳糖
1.Isolation and enrichment of fetal nucleated red blood cells by using N-acetylgalactosamine-specific lectin;N-乙酰半乳糖特异性植物凝素分离和富集胎儿有核红细胞
6)N- acetylgalactosamineN-乙酰半乳糖胺
1.Objective To investigate the relationship between serum IgA1 molecular N- acetylgalactosamine abnormality and pathological manifestations of nephropathy among Mongolian ethnicity and Han group in Inner Mongolia region.目的探讨内蒙地区蒙古族与汉族人群IgA肾病患者血清IgA1分子N-乙酰半乳糖胺异常程度与肾脏病理表现的关系。
延伸阅读

[3-(aminosulfonyl)-4-chloro-N-(2.3-dihydro-2-methyl-1H-indol-1-yl)benzamide]分子式:C16H16ClN3O3S分子量:365.5CAS号:26807-65-8性质:暂无制备方法:暂无用途:用于轻、中度原发性高血压。